Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA minor version update was applied: from v3.4.1 to v3.4.2, with no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the site's revision tag; this change is cosmetic and does not modify any study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a 'Show glossary' option and updated labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This is a metadata update and does not change the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check68 days agoChange DetectedDifference1%

- Check89 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2. Substantive study content such as the title, eligibility criteria, interventions, and locations remains unchanged.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.